Evidence map›Paper›PMID 27810914›Full record

ArticleThe Journal of cell biology2016

Nuclear calcium is required for human T cell activation.

Sara Monaco, Beate Jahraus, Yvonne Samstag, Hilmar Bading

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of cell biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 27 citations in OpenAlex.

  1. Multi-Omics Integration IdentifiesInternational journal of molecular sciences · 2025
    Article
  2. Article
  3. IL-21, Inflammatory Cytokines and Hyperpolarized CD8Antioxidants (Basel, Switzerland) · 2023
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. MIDD0301 - A first-in-class anti-inflammatory asthma drug targets GABABasic & clinical pharmacology & toxicology · 2019
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Sara MonacoInterdisciplinary Center for Neurosciences, Department of Neurobiology, Heidelberg University, 69120 Heidelberg, Germany.ORCID http://orcid.org/0000-0001-7229-7075
Beate JahrausInstitute of Immunology, Section Molecular Immunology, Heidelberg University, 69120 Heidelberg, Germany.ORCID http://orcid.org/0000-0002-5697-4977
Yvonne SamstagInstitute of Immunology, Section Molecular Immunology, Heidelberg University, 69120 Heidelberg, Germany.
Hilmar BadingInterdisciplinary Center for Neurosciences, Department of Neurobiology, Heidelberg University, 69120 Heidelberg, Germany bading@nbio.uni-heidelberg.de.
Heidelberg University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Calcium signals in stimulated T cells are generally considered single entities that merely trigger immune responses, whereas costimulatory events specify the type of reaction. Here we show that the "T cell calcium signal" is a composite signal harboring two distinct components that antagonistically control genomic programs underlying the immune response. Using human T cells from healthy individuals, we establish nuclear calcium as a key signal in human T cell adaptogenomics that drives T cell activation and is required for signaling to cyclic adenosine monophosphate response element-binding protein and the induction of CD25, CD69, interleukin-2, and γ-interferon. In the absence of nuclear calcium signaling, cytosolic calcium activating nuclear factor of activated T cells translocation directed the genomic response toward enhanced expression of genes that negatively modulate T cell activation and are associated with a hyporesponsive state. Thus, nuclear calcium controls the T cell fate decision between a proliferative immune response and tolerance. Modulators of nuclear calcium-driven transcription may be used to develop a new type of pro-tolerance immunosuppressive therapy.

Indexed as

BiomarkersCalciumCalcium SignalingCell NucleusCells, CulturedClonal AnergyCyclic AMP Response Element-Binding ProteinCyclic AMP Response Element ModulatorCytokinesGene Expression ProfilingHumansLymphocyte ActivationModels, BiologicalNFATC Transcription FactorsProtein TransportReceptors, Antigen, T-CellBiomarkersCalciumCREM protein, humanCyclic AMP Response Element-Binding ProteinCyclic AMP Response Element ModulatorCytokinesNFATC Transcription FactorsReceptors, Antigen, T-Cell

Identifiers

PMID27810914
PMCPMC5084645
OpenAlexW2539141378

What Socratic holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.